VCM
ZBIO

Voleon Capital Management’s Zenas BioPharma ZBIO Stock Holding History

Voleon Capital Management’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.24M Buy
167,145
+137,533
+464% +$2.73M 0.08% 246
2026
Q1 		$579K Buy
29,612
+19,425
+191% +$436K 0.01% 542
2025
Q4 		$370K Buy
+10,187
New +$335K 0.01% 637

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Voleon Capital Management's ZBIO Position: Q2 2026 in Review

Voleon Capital Management increased its Zenas BioPharma (ZBIO) stake by 464% in Q2 2026, buying an estimated $2.73M and bringing the position to 167,145 shares worth $4.24M. The position accounts for 0.08% of the portfolio, ranked #246.

Voleon Capital Management first reported a position in ZBIO in Q4 2025 and has held it in 3 quarters since. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

  • Voleon Capital Management held 167,145 shares of Zenas BioPharma worth $4.24M as of Q2 2026.
  • Voleon Capital Management bought 137,533 Zenas BioPharma shares in Q2 2026, an estimated $2.73M.
  • Zenas BioPharma made up 0.08% of Voleon Capital Management's portfolio in Q2 2026, its #246 holding.
  • Voleon Capital Management first reported a position in Zenas BioPharma in Q4 2025 and has held it in 3 quarters since.
  • 144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.